Celltrion
068270.KS
#741
Rank
A$42.60 B
Marketcap
$197.97
Share price
0.33%
Change (1 day)
-20.24%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.50

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.81. In 2022 the company made an earnings per share (EPS) of $4.68 a decrease over its 2021 EPS that were of $5.56.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.50-3.97%
2022$4.68-15.84%
2021$5.5612.77%
2020$4.9370.79%
2019$2.8915.63%
2018$2.50-33.13%
2017$3.74141.17%
2016$1.558.28%
2015$1.4311.28%
2014$1.2916.37%
2013$1.10-67.42%
2012$3.3984.22%
2011$1.8462.13%
2010$1.1480.61%
2009$0.63-559.63%
2008-$0.14-123.16%
2007$0.59